User talk:HPEricSh

After completing the edits, provide guidance to your group’s peer reviewers by noting the goals and focus of the group’s edits, and which sections of the article were prioritized, using the “Talk” page.

The antiviral drug page is lacking in policy information as well as other information very relevant to public use, such as stigma and the "anti-vax" movement. Our focus was to provide four areas of improvement:

• Within a new policy section, create a subsection that discusses costs of antivirals and other pharmaceuticals, making note of why costs are so high.
• Within the same policy section, create a subsection that considers negative perceptions (stigma) towards vaccines. Discuss the definition of vaccines, policies surrounding vaccination, and recent rising stigma towards vaccination.
• Within the same policy section, create a subsection that discusses the use, distribution, and stockpiling of antivirals.
• Within the existing "Acquired resistance" section, provide more relevant and in-depth information regarding this important topic.

We endeavored to keep the quality of our edits consistent with the rest of the article, accurately referencing relevant literature and providing links to other Wikipedia pages when necessary. In this manner, we hoped to add to the purely biochemical nature of the antiviral drug page, providing a policy, perception, and cost scope while enhancing existing sections on resistance.

Author Contributions

DC, ES, CB, and SP drafted sections 1.1, 1.2, 1.3, and 2, respectively. ES provided initial sandbox edits/formatting and "Talk" page text and DC compiled/finalized sandbox. All contributed to final edits, ES integrated Sandbox content with actual article.